BNP Paribas Financial Markets
ETRM

BNP Paribas Financial Markets’s EnteroMedics Inc. ETRM Stock Holding History

BNP Paribas Financial Markets’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2
Closed -$3.66K – 4536
2014
Q2 		$3.66K Hold
2
– – ﹤0.01% 2766
2014
Q1 		$4.27K Hold
2
– – ﹤0.01% 2441
2013
Q4 		$4.79K Buy
+2
New +$3.22K ﹤0.01% 3123

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BNP Paribas Financial Markets's ETRM Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of EnteroMedics Inc. (ETRM) in Q3 2014, closing a stake of 2 shares — an estimated $3.66K sold.

BNP Paribas Financial Markets first reported a position in ETRM in Q4 2013 and held it in 3 quarters. The position peaked at $4.79K in Q4 2013. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining EnteroMedics Inc. position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 EnteroMedics Inc. shares in Q3 2014, an estimated $3.66K.
  • BNP Paribas Financial Markets first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's EnteroMedics Inc. position peaked at $4.79K in Q4 2013.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.